AWM
ASND icon

Altium Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

Altium Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,367
Closed -$498K – 341
2020
Q2 		$498K Buy
3,367
+1,065
+46% +$146K 0.06% 162
2020
Q1 		$259K Buy
+2,302
New +$299K 0.04% 244

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Altium Wealth Management's ASND Position: Q3 2020 in Review

Altium Wealth Management sold out of Ascendis Pharma A/S (ASND) in Q3 2020, closing a stake of 3,367 shares — an estimated $498K sold.

Altium Wealth Management first reported a position in ASND in Q1 2020 and held it in 2 quarters. The position peaked at $498K in Q2 2020. 152 funds tracked by Wall St. Rank hold ASND as of Q3 2020.

  • Altium Wealth Management reported no remaining Ascendis Pharma A/S position as of Q3 2020 after selling out during the quarter.
  • Altium Wealth Management sold 3,367 Ascendis Pharma A/S shares in Q3 2020, an estimated $498K.
  • Altium Wealth Management first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 2 quarters.
  • Altium Wealth Management's Ascendis Pharma A/S position peaked at $498K in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2020.

Based on Altium Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.